Guangzhou Industry and Information Technology Bureau delegation visits Reforgene

On May 11, 2026, Zhang Jianhua, Director of the Guangzhou Municipal Industry and Information Technology Bureau, led a team to Guangzhou Reforgene Medicine Co., Ltd. ("Reforgene") for a special research visit, accompanied by relevant leaders including those from the Municipal Financial Affairs Office. Dr. Liang Junbin, CEO of Reforgene, warmly received the delegation and delivered a work report.

At the discussion, Liang Junbin introduced that Reforgene has been deeply engaged in gene editing for many years, achieving important breakthroughs in gene editing treatment of genetic diseases and complex diseases, with smooth progress in the R&D of multiple innovative drugs, and is committed to providing patients with safer and more accessible curative treatment options. In the future, the company will focus on clinical translation and industrial implementation, steadily advance product overseas expansion and internationalization, and help the high-quality development of China's gene editing technology.

Zhang Jianhua affirmed Reforgene's innovative progress, pointing out that the cell and gene industry is an important part of Guangzhou's future industries and of great significance to upgrading the level of the biomedical industry. The two sides held in-depth exchanges on key work including corporate financing, product overseas expansion and policy support. Zhang Jianhua said that the Municipal Industry and Information Technology Bureau will strongly support quality enterprises such as Reforgene and continuously optimize services.